Interferon-α and Autoimmune Thyroid Disease
Abstract
Interferon-alpha (IFN alpha) is the main therapeutic agent in patients infected with the hepatitis C virus (HCV). It is rather safe, but is known to induce the production of autoantibodies and can lead to the occurrence of autoimmune disease. This minireview focuses on the induction of autoimmune thyroid disease (AITD) in HCV-infected patients treated with IFN alpha. Females carry a higher risk to develop AITD upon IFN alpha treatment, with a relative risk of 4.4 (95% confidence interval 3.2-5.9). The presence of thyroid peroxidase antibodies before therapy has a relative risk for AITD of 3.9 (95% confidence interval 1.9-8.1). IFN alpha-associated AITD can consist of autoimmune primary hypothyroidism, Graves' hyperthyroidism, and destructive thyroiditis, with hypothyroidism being the most common side effect. The clear association between AITD and IFN alpha use suggests that high endogenous IFN alpha levels may also be associated with naturally occurring AITD. High endogenous IFN alpha levels are seen in patients infected with certain viruses. It is concluded that IFN alpha is one of the environmental factors capable of triggering the onset of AITD in genetically susceptible individuals.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In a review of published cases from eight series, 69% of 49 patients with IFN-a-associated thyrotoxicosis for whom an etiology was identified were found to have GD.
“In a review of published cases from eight series, 69% of 49 patients with IFN-a-associated thyrotoxicosis for whom an etiology was identified were found to have GD, based on either positive TRAb titers or requirement for a prolonged course of ATDs ( 640).”
From 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (2016) · cites this paper as [640]
Cites
Lauer, G. M., & Walker, B. D. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107053450107 · Cited by 3,010 · see citing works
An overview of the immune system
Parkin, J., & Cohen, B. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04904-7 · Cited by 1,463 · see citing works
Interferons α and β as Immune Regulators—A New Look
Biron, C. A. (2001) · Immunity · doi:10.1016/s1074-7613(01)00154-6 · Cited by 670 · see citing works
Autoimmune Thyroid Disease: Further Developments in Our Understanding*
Weetman, A. P., & McGregor, A. M. (1994) · Endocrine Reviews · doi:10.1210/edrv-15-6-788 · Cited by 660 · see citing works
Fattovich, G., Giustina, G., Favarato, S., & Ruol, A. (1996) · Journal of Hepatology · doi:10.1016/s0168-8278(96)80184-x · Cited by 483 · see citing works
Side effects of high-dose interferon therapy for chronic hepatitis C
Okanoue, T., Sakamoto, S., Itoh, Y., Minami, M., Yasui, K., Sakamoto, M., Nishioji, K., Katagishi, T., Nakagawa, Y., Tada, H., et al. (1996) · Journal of Hepatology · doi:10.1016/s0168-8278(96)80113-9 · Cited by 456 · see citing works
Molecular Pathways in Virus-Induced Cytokine Production
Mogensen, T. H., & Paludan, S. R. (2001) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.65.1.131-150.2001 · Cited by 418 · see citing works
Side effects of α interferon in chronic hepatitis C
Dusheiko, G. M. (1997) · Hepatology · doi:10.1002/hep.510260720 · Cited by 394 · see citing works
Autoimmune thyroid disease: further developments in our understanding
Weetman, A. P. (1994) · Endocrine Reviews · doi:10.1210/er.15.6.788 · Cited by 216 · see citing works
Marazuela, M., Garcı́a-Buey, L., González‐Fernández, B., García‐Monzón, C., Arranz, A., Borque, M. J., & Moreno‐Otero, R. (1996) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1996.751768.x · Cited by 210 · see citing works
Fernandez-Soto, L., González, A., Escobar‐Jiménez, F., Vázquez, R., Ocete, E., Olea, N., & Salmerón, J. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.13.1445 · Cited by 197 · see citing works
Roti, E., Minelli, R., Giuberti, T., Marchelli, S., Schianchi, C., Gardini, E., Salvi, M., Fiaccadori, F., Ugolotti, G., Neri, T. M., et al. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(96)00259-8 · Cited by 195 · see citing works
KOH, L. K. H., GREENSPAN, F. S., & YEO, P. P. B. (1997) · Thyroid · doi:10.1089/thy.1997.7.891 · Cited by 185 · see citing works
Immune-mediated side-effects of cytokines in humans
Vial, T. (1995) · Toxicology · doi:10.1016/0300-483x(95)03124-x · Cited by 183 · see citing works
Thyroid abnormalities in chronic viral hepatitis and their relationship to interferon alfa therapy
Deutsch, M. J., Dourakis, S. P., Manesis, E. K., Gioustozi, A., Hess, G., Horsch, A., & Hadziyannis, S. J. (1997) · Hepatology · doi:10.1002/hep.510260127 · Cited by 182 · see citing works
Chehadeh, W., Weill, J., Vantyghem, M., Alm, G., Lefèbvre, J., Wattré, P., & Hober, D. (2000) · The Journal of Infectious Diseases · doi:10.1086/315516 · Cited by 179 · see citing works
Autoimmunity induced by interferon-α therapy for chronic viral hepatitis
Dumoulin, F. L., Leifeld, L., Sauerbruch, T., & Spengler, U. (1999) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(99)80095-x · Cited by 123 · see citing works
Insulin-dependent diabetes mellitus during alpha-interferon therapy for chronic viral hepatitis
Fabris, P., Betterle, C., Greggio, N. A., Zanchetta, R., Bosi, E., Biasin, M. R., & de Lalla, F. (1998) · Journal of Hepatology · doi:10.1016/s0168-8278(98)80328-0 · Cited by 112 · see citing works
Thyrotoxicosis induced by alpha‐interferon therapy in chronic viral hepatitis
Wong, V., Fu, A. X., George, J., & Cheung, N. W. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01553.x · Cited by 106 · see citing works
Mj, H., Tsai, S., Huang, B., Sheen, I., Yeh, C., & Liaw, Y. (1999) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1999.00686.x · Cited by 103 · see citing works
Hepatitis C virus infection, alpha interferon therapy and thyroid dysfunction
Marcellin, P., Pouteau, M., & Benhamou, J. (1995) · Journal of Hepatology · doi:10.1016/0168-8278(95)80291-6 · Cited by 99 · see citing works
Type I interferons and T helper development
Farrar, J. D., & Murphy, K. M. (2000) · Immunology Today · doi:10.1016/s0167-5699(00)01710-2 · Cited by 97 · see citing works
Mc, H., Yu, M., Chuang, W., Shin, S., Dai, C., Chen, S., Lin, Z.-Y., Hsieh, M., Liu, J., Wang, L., et al. (2000) · European Journal of Endocrinology · doi:10.1530/eje.0.1420431 · Cited by 88 · see citing works
Kakizaki, S., Takagi, H., Murakami, M., Takayama, H., & Mori, M. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80131-7 · Cited by 76 · see citing works
Carella, C. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.5.1925 · Cited by 55 · see citing works
Uto, H., Matsuoka, H., Murata, M., Okamoto, T., Miyata, Y., Hori, T., Ido, A., Hirono, S., Hayashi, K., & Tsubouchi, H. (2000) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(00)00143-1 · Cited by 36 · see citing works
Chen, F., Okamura, K., Sato, K., Kuroda, T., Mizokami, T., Fujikawa, M., Tsuji, H., Okamura, S., & Fujishima, M. (1996) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1996.d01-1564.x · Cited by 21 · see citing works
Autoimmunity and endocrinology
Weetman, A. P. (2009) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0029-1212152 · Cited by 14 · see citing works
Yue, S., Enomoto, T., Matsumoto, Y., Kawai, K., & Volpe, R. J. (1998) · Thyroid · doi:10.1089/thy.1998.8.755 · Cited by 13 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Ross, D. S., Burch, H. B., Cooper, D. S., Greenlee, M. C., Laurberg, P., Maia, A. L., Rivkees, S. A., Samuels, M., Sosa, J. A., Stan, M. N., et al. (2016) · Thyroid® · doi:10.1089/thy.2016.0229 · Cited by 2,938 · see citing works
“In a review of published cases from eight series, 69% of 49 patients with IFN-a–associated thyrotoxicosis for whom an etiology was identified were found to have GD, based on either positive TRAb titers or requirement for a prolonged course of ATDs (640).”
BackgroundSelf-citationBahn, R. S., Burch, H. B., Cooper, D. S., Garber, J. R., Greenlee, M. C., Klein, I., Laurberg, P., McDougall, I. R., Montori, V. M., Rivkees, S. A., et al. (2011) · Endocrine Practice · doi:10.4158/ep.17.3.456 · Cited by 1,098 · see citing works
Self-citationThe American Thyroid Association and American Association of Clinical Endocrinologists Taskforce on Hyperthyroidism and Other Causes of Thyrotoxicosis, Bahn, R. S., Burch, H. B., Cooper, D. S., Garber, J. R., Greenlee, M. C., Klein, I., Laurberg, P., McDougall, I. R., Montori, V. M., et al. (2011) · Thyroid · doi:10.1089/thy.2010.0417 · Cited by 898 · see citing works
Self-citationCross-regulation of TNF and IFN-α in autoimmune diseases
Palucka, K., Blanck, J.-P., Bennett, L. B., Pascual, V., & Banchereau, J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408506102 · Cited by 518 · see citing works
The environment and autoimmune thyroid diseases
Prummel, M. F., Strieder, T. G. A., & Wiersinga, W. M. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1500605 · Cited by 298 · see citing works
Self-citationBreaking Tolerance to Thyroid Antigens: Changing Concepts in Thyroid Autoimmunity
McLachlan, S. M., & Rapoport, B. (2013) · Endocrine Reviews · doi:10.1210/er.2013-1055 · Cited by 256 · see citing works
Extrahepatic manifestations of chronic HCV infection.
Galossi, A., Guarisco, R., Bellis, L., & Puoti, C. (2007) · PubMed · Cited by 195 · see citing works
The clinical and physiological spectrum of interferon‐alpha induced thyroiditis
Mandac, J. C., Chaudhry, S., Sherman, K. E., & Tomer, Y. (2006) · Hepatology · doi:10.1002/hep.21146 · Cited by 193 · see citing works
Side Effects of Cytokines Approved for Therapy
Baldo, B. A. (2014) · Drug Safety · doi:10.1007/s40264-014-0226-z · Cited by 189 · see citing works
Thyroid peroxidase autoantibodies in euthyroid subjects
Prummel, M. F., & Wiersinga, W. M. (2005) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2004.11.003 · Cited by 178 · see citing works
Self-citationPharmacology and therapeutic potential of interferons
George, P. M., Badiger, R., Alazawi, W., Foster, G. R., & Mitchell, J. A. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.03.006 · Cited by 176 · see citing works
The interplay between thyroid and liver: implications for clinical practice
Piantanida, E., Ippolito, S., Gallo, D., Masiello, E., Premoli, P., Cusini, C., Rosetti, S., Sabatino, J., Segato, S., Trimarchi, F., et al. (2020) · Journal of Endocrinological Investigation · doi:10.1007/s40618-020-01208-6 · Cited by 180 · see citing works
Type I Interferons in the Pathogenesis and Treatment of Autoimmune Diseases
Jiang, J., Zhao, M., Chang, C. C.-C., Wu, H., & Lu, Q. (2020) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-020-08798-2 · Cited by 160 · see citing works
Management of adverse effects of Peg-IFN and ribavirin therapy for hepatitis C
Sulkowski, M., Cooper, C., Hunyady, B., Jia, J., Ogurtsov, P. P., Peck‐Radosavljevic, M., Shiffman, M. L., Yurdaydın, C., & Dalgård, O. (2011) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2011.21 · Cited by 149 · see citing works
Interferon Alpha Treatment and Thyroid Dysfunction
Tomer, Y., Blackard, J. T., & Akeno, N. (2007) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2007.07.001 · Cited by 142 · see citing works
Thyroid Disorders in Chronic Hepatitis C Virus Infection
Antonelli, A., Ferri, C., Fallahi, P., Ferrari, S. M., Ghinoi, A., Rotondi, M., & Ferrannini, E. (2006) · Thyroid · doi:10.1089/thy.2006.16.563 · Cited by 136 · see citing works
Interferon-α-Related Thyroid Disease: Pathophysiological, Epidemiological, and Clinical Aspects
Carella, C., Mazziotti, G., Amato, G., Braverman, L., & Roti, E. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0627 · Cited by 132 · see citing works
Coco, G., Dal Pra, C., Presotto, F., Albergoni, M. P., Canova, C., Pedini, B., Zanchetta, R., Chen, S., Furmaniak, J., Rees Smith, B., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0860 · Cited by 127 · see citing works
Low Serum Vitamin D Is Associated with Anti-Thyroid Peroxidase Antibody in Autoimmune Thyroiditis
Shin, D. Y., Kim, K. J., Kim, D., Hwang, S., & Lee, E. J. (2014) · Yonsei Medical Journal · doi:10.3349/ymj.2014.55.2.476 · Cited by 122 · see citing works
Hypothyroidism in the Elderly: Pathophysiology, Diagnosis and Treatment
Laurberg, P., Andersen, S., Pedersen, I. B., & Carl, A. B. (2005) · Drugs & Aging · doi:10.2165/00002512-200522010-00002 · Cited by 141 · see citing works
Self-citationHepatitis C and interferon induced thyroiditis
Tomer, Y. (2009) · Journal of Autoimmunity · doi:10.1016/j.jaut.2009.11.008 · Cited by 119 · see citing works
Cytokines and HCV-Related Disorders
Fallahi, P., Ferri, C., Ferrari, S. M., Corrado, A., Sansonno, D. E., & Antonelli, A. (2012) · Clinical and Developmental Immunology · doi:10.1155/2012/468107 · Cited by 116 · see citing works
Thyroid Peroxidase as an Autoantigen
McLachlan, S. M., & Rapoport, B. (2007) · Thyroid · doi:10.1089/thy.2007.0169 · Cited by 115 · see citing works
Endocrine manifestations of hepatitis C virus infection
Antonelli, A., Ferri, C., Ferrari, S. M., Colaci, M., Sansonno, D. E., & Fallahi, P. (2008) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet1027 · Cited by 113 · see citing works
Interferon induced thyroiditis
Tomer, Y., & Menconi, F. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2009.07.004 · Cited by 112 · see citing works
The Role of BAFF System Molecules in Host Response to Pathogens
Sakai, J., & Akkoyunlu, M. (2017) · Clinical Microbiology Reviews · doi:10.1128/cmr.00046-17 · Cited by 109 · see citing works
Harii, N., Lewis, C. J., Vasko, V., McCall, K. D., Benavides-Peralta, U., Sun, X., Ringel, M. D., Saji, M., Giuliani, C., Napolitano, G., et al. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0100 · Cited by 106 · see citing works
Fabiani, S., Fallahi, P., Ferrari, S. M., Miccoli, M., & Antonelli, A. (2018) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-017-9440-1 · Cited by 96 · see citing works
Extrahepatic Manifestations of Hepatitis C Virus Infection
Zignego, A. L., & Craxı̀, A. (2008) · Clinics in Liver Disease · doi:10.1016/j.cld.2008.03.012 · Cited by 90 · see citing works
Extrahepatic Manifestations and Autoantibodies in Patients with Hepatitis C Virus Infection
Himoto, T., & Masaki, T. (2012) · Clinical and Developmental Immunology · doi:10.1155/2012/871401 · Cited by 89 · see citing works
Thyroid dysfunctions secondary to cancer immunotherapy
Chalan, P., Dalmazi, G. D., Pani, F., Remigis, A. D., Corsello, A., & Caturegli, P. (2017) · Journal of Endocrinological Investigation · doi:10.1007/s40618-017-0778-8 · Cited by 81 · see citing works
Thyroid Cancer in HCV-Related Chronic Hepatitis Patients: A Case-Control Study
Antonelli, A., Ferri, C., Fallahi, P., Pampana, A., Ferrari, S. M., Barani, L., Marchi, S., & Ferrannini, E. (2007) · Thyroid · doi:10.1089/thy.2006.0194 · Cited by 79 · see citing works
Muller, I., Moran, C., Lecumberri, B., Decallonne, B., Robertson, N., Jones, J., & Dayan, C. M. (2019) · European Thyroid Journal · doi:10.1159/000500881 · Cited by 78 · see citing works
“Thyroid dysfunction (TD) is a common side effect of many treatments acting with different mechanisms, including but not limited to interferon alpha [1], interleukin-2 [2], thalidomide [3], amiodarone [4], radiation therapy [5], lithium [6], bexarotene [7], immune check-point inhibitors [8], and…”
BackgroundAutoimmune manifestations in viral hepatitis
Vergani, D., & Mieli‐Vergani, G. (2012) · Seminars in Immunopathology · doi:10.1007/s00281-012-0328-6 · Cited by 75 · see citing works
Effects of Vitamin D treatment on thyroid autoimmunity
Şimşek, Y., Cakır, I., Yetmiş, M., Dizdar, O. S., Başpınar, O., & Gökay, F. (2016) · Journal of Research in Medical Sciences · doi:10.4103/1735-1995.192501 · Cited by 71 · see citing works
Investigating the shared genetic architecture between hypothyroidism and rheumatoid arthritis
Peng, Z., Huang, W., Tang, M., Chen, B., Yang, R., Liu, Q., Liu, C., & Long, P. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1286491 · Cited by 68 · see citing works
Type 1 Diabetes and Interferon Therapy
Nakamura, K., Kawasaki, E., Imagawa, A., Awata, T., Ikegami, H., Uchigata, Y., Kobayashi, T., Shimada, A., Nakanishi, K., Makino, H., et al. (2011) · Diabetes Care · doi:10.2337/dc10-2274 · Cited by 68 · see citing works
Antonelli, A., Ferrari, S. M., Fallahi, P., Ghiri, E., Crescioli, C., Romagnani, P., Vitti, P., Serio, M., & Ferrannini, E. (2010) · Cytokine · doi:10.1016/j.cyto.2010.01.009 · Cited by 68 · see citing works
Interferon induced Autoimmune Thyroid Disease (AITD): a model for human autoimmunity
Oppenheim, Y. L., Ban, Y., & Tomer, Y. (2004) · Autoimmunity Reviews · doi:10.1016/j.autrev.2004.03.003 · Cited by 68 · see citing works
Ferri, S., Muratori, L., Lenzi, M., Granito, A., Bianchi, F. B., & Vergani, D. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208784746824 · Cited by 65 · see citing works
Baldazzi, V., Tassi, R., Lapini, A., Santomaggio, C., Carini, M., & Mazzanti, R. (2010) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2010.07.015 · Cited by 64 · see citing works
Caraccio, N., Giannini, R., Cuccato, S., Faviana, P., Berti, P., Galleri, D., Dardano, A., Basolo, F., Ferrannini, E., & Monzani, F. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1173 · Cited by 63 · see citing works
Interferon Family Cytokines in Obesity and Insulin Sensitivity
Huang, L.-Y., Chiu, C.-J., Hsing, C., & Hsu, Y. (2022) · Cells · doi:10.3390/cells11244041 · Cited by 57 · see citing works
Environmental triggers of thyroiditis: Hepatitis C and interferon-α
Menconi, F., Hasham, A., & Tomer, Y. (2011) · Journal of Endocrinological Investigation · doi:10.1007/bf03346699 · Cited by 57 · see citing works
Interferon alpha and neuromuscular disorders
Stübgen, J. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.12.008 · Cited by 56 · see citing works
Kee, K., Lee, C., Wang, J., Tung, H., Changchien, C., Lu, S., & Wang, P. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2005.03947.x · Cited by 54 · see citing works
Indolfi, G., Stagi, S., Bartolini, E., Salti, R., de Martino, M., Azzari, C., & Resti, M. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.03009.x · Cited by 54 · see citing works
Sunitinib (Sutent)-Induced Thyrotoxicosis Due to Destructive Thyroiditis: A Case Report
Faris, J. E., Moore, A. F., & Daniels, G. H. (2007) · Thyroid · doi:10.1089/thy.2007.0104 · Cited by 54 · see citing works
COVID-induced thyroid autoimmunity
Brancatella, A., Viola, N., Santini, F., & Latrofa, F. (2023) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2023.101742 · Cited by 48 · see citing works
Hepatitis C infection: a systemic disease with extrahepatic manifestations.
Ali, A. Y., & Zein, N. N. (2005) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.72.11.1005 · Cited by 48 · see citing works
Weetman, A. P. (2014) · Clinical Endocrinology · doi:10.1111/cen.12427 · Cited by 46 · see citing works
Thyroid dysfunction in patients with chronic hepatitis C: Virus‐ or therapy‐related?
Vezali, E., Elefsiniotis, I. S., Mihas, C. C., Konstantinou, E. A., & Saroglou, G. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2009.05812.x · Cited by 45 · see citing works
Autoantibodies in chronic hepatitis C: A clinical perspective
Narciso-Schiavon, J. L. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i8.1074 · Cited by 44 · see citing works
Pastore, F. (2016) · World Journal of Hepatology · doi:10.4254/wjh.v8.i2.83 · Cited by 43 · see citing works
Do serum biomarkers really measure breast cancer?
Jesneck, J. L., Mukherjee, S., Yurkovetsky, Z. R., Clyde, M. A., Marks, J. R., Lokshin, A. E., & Lo, J. Y.-C. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-164 · Cited by 42 · see citing works
Side effects of medical therapy for chronic hepatitis C
Shiffman Mitchell, L. (2004) · Annals of Hepatology · doi:10.1016/s1665-2681(19)32118-0 · Cited by 41 · see citing works
Thyroid dysfunction (TD) among chronic hepatitis C patients with mild and severe hepatic fibrosis
Rodriguez‐Torres, M., Ríos‐Bedoya, C. F., Ortiz‐Lasanta, G., Marxuach-Cuétara, A. M., & Jiménez‐Rivera, J. (2008) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31891-5 · Cited by 39 · see citing works
Thyroid disorders in patients with chronic hepatitis C using interferon-alpha and ribavirin therapy
Andrade, L. J. D. O., Atta, A. M., Atta, M. L. B. D. S., Mangabeira, C. N. K., & Paraná, R. (2011) · The Brazilian Journal of Infectious Diseases · doi:10.1016/s1413-8670(11)70208-2 · Cited by 37 · see citing works
Thyroid dysfunction in hepatitis C individuals treated with interferon-alpha and ribavirin: a review
Andrade, L. J. D. O., Atta, A. M., D'Almeida, A., & Paraná, R. (2008) · The Brazilian Journal of Infectious Diseases · doi:10.1590/s1413-86702008000200009 · Cited by 37 · see citing works
Poma, A. M., Basolo, A., Bonuccelli, D., Proietti, A., Macerola, E., Ugolini, C., Torregrossa, L., Alì, G., Giannini, R., Vignali, P., et al. (2021) · Thyroid · doi:10.1089/thy.2021.0345 · Cited by 36 · see citing works
Ruiz‐Riol, M., Armengol, M. P., Colobrán, R., Sánchez‐Pla, Á., Borràs, F. E., Lucas, A., Martínez-Cáceres, E. M., & Pujol‐Borrell, R. (2011) · Journal of Autoimmunity · doi:10.1016/j.jaut.2011.01.002 · Cited by 35 · see citing works
Mazziotti, G., Sorvillo, F., Piscopo, M., Morisco, F., Cioffi, M., Stornaiuolo, G., Gaeta, G. B., Molinari, A. M., Lazarus, J. H., Amato, G., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0093 · Cited by 35 · see citing works
Sorafenib Induced Thyroiditis in Two Patients with Hepatocellular Carcinoma
van Doorn, L., Eskens, F. A. L. M., Visser, T. J., van der Lugt, A., Mathijssen, R. H. J., & Peeters, R. P. (2011) · Thyroid · doi:10.1089/thy.2010.0234 · Cited by 34 · see citing works
Lévy-Bohbot, N., Young, J., Orgiazzi, J., Buffet, C., François, M., Bernard‐Chabert, B., Lukas-Croisier, C., & Delemer, B. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02104 · Cited by 34 · see citing works
Prevalence of HCV antibodies in autoimmune thyroid disease.
Testa, A. C., Castaldi, P. J., Fant, Gf, F., Grieco, De Rosa, A., Mg, P., & Rosa, G. D. (2006) · PubMed · Cited by 34 · see citing works
Satzger, I., Meier, A., Schenck, F., Kapp, A., Hauschild, A., & Gutzmer, R. (2007) · International Journal of Cancer · doi:10.1002/ijc.22951 · Cited by 33 · see citing works
Costelloe, S. J., Wassef, N., Schulz, J., Vaghjani, T., Morris, C. J., Whiting, S., Thomas, M., Dusheiko, G. M., Jacobs, M., & Vanderpump, M. P. J. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03785.x · Cited by 32 · see citing works
Opportunistic autoimmune disorders
Kong, Y. M., Wei, W., & Tomer, Y. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05138.x · Cited by 33 · see citing works
Determinants of thyroid autoantibody production in Hashimoto’s thyroiditis
Zaletel, K. (2007) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.3.2.217 · Cited by 32 · see citing works
Autoimmune and Neoplastic Thyroid Diseases Associated with Hepatitis C Chronic Infection
Fallahi, P., Ferrari, S. M., Politti, U., Giuggioli, D., Ferri, C., & Antonelli, A. (2014) · International Journal of Endocrinology · doi:10.1155/2014/935131 · Cited by 31 · see citing works
Tran, H. A., Attia, J., Levett-Jones, T. L., & Batey, R. G. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04771.x · Cited by 31 · see citing works
Panicker, S. P., Ganguly, T., Consolo, M. C., Price, V. H., Mirmirani, P., Honda, K. S., & Karnik, P. S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038449 · Cited by 30 · see citing works
Friedrich-Rust, M., Theobald, J., Zeuzem, S., & Bojunga, J. (2009) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2008.01059.x · Cited by 30 · see citing works
Zhao, T., Zhang, Y., Wang, F., Zhang, B., Chen, Q., Liu, L., Yan, L., Yang, Y., Meng, Q., Huang, J., et al. (2023) · PubMed Central · doi:10.1007/s11032-022-01351-3 · Cited by 29 · see citing works
Kesavachandran, C. N., Haamann, F., & Nienhaus, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055364 · Cited by 29 · see citing works
Hepatitis C virus infection and risk of thyroid cancer: A systematic review and meta-analysis
Wang, P., Jing, Z., Liu, C., Xu, M., Wang, P., Wang, X., Yin, Y., Cui, Y., Ren, D., & Rao, X. (2017) · Arab Journal of Gastroenterology · doi:10.1016/j.ajg.2017.01.003 · Cited by 28 · see citing works
Extrahepatic Manifestations of Hepatitis C Virus
Viganò, M., & Colombo, M. (2015) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2015.07.006 · Cited by 26 · see citing works
Thyroid dysfunction in patients with hepatitis C on IFN-α therapy
Antonelli, A., Ferri, C., & Fallahi, P. (2009) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2009.168 · Cited by 26 · see citing works
Tran, H. A., Reeves, G. E. M., & Jones, T. L. (2008) · QJM · doi:10.1093/qjmed/hcn150 · Cited by 25 · see citing works
Tran, H. A., Levett-Jones, T. L., & Batey, R. G. (2005) · BMC Endocrine Disorders · doi:10.1186/1472-6823-5-8 · Cited by 24 · see citing works
Yan, Z., Fan, K., Yi, F., Wang, X., Mao, Q., Deng, G., & Wang, Y. (2012) · Hepatitis Monthly · doi:10.5812/hepatmon.6390 · Cited by 23 · see citing works
Restless legs syndrome due to interferon‐α
LaRochelle, J. S., & Karp, B. I. (2004) · Movement Disorders · doi:10.1002/mds.20049 · Cited by 23 · see citing works
Antonelli, A., Ferrari, S. M., Mancusi, C., Mazzi, V., Pupilli, C., Centanni, M., Ferri, C., Ferrannini, E., & Fallahi, P. (2012) · Immunobiology · doi:10.1016/j.imbio.2012.08.267 · Cited by 22 · see citing works
Is hepatitis C virus a risk factor for thyroid autoimmunity?
Floreani, A., Betterle, C., Carderi, I., Presotto, F., Pedini, B., Moscon, A., Andrea, O. D., & Chiaramonte, M. (2006) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2005.00699.x · Cited by 22 · see citing works
Matsuse, D., Ochi, H., Tashiro, K., NOMURA, T., Murai, H., Taniwaki, T., & Kira, J. (2005) · Internal Medicine · doi:10.2169/internalmedicine.44.68 · Cited by 21 · see citing works
Masood, N., Ghori, R. A., Memon, A., Memon, S., Memon, K. I., Memon, I. A., Jaffri, M., & Baloch, G. H. (2008) · PubMed · Cited by 21 · see citing works
Nadeem, A., Aslam, M. N., Khan, D. A., Hussain, T., & Khan, S. (2009) · PubMed · Cited by 20 · see citing works
Yang, J., Kao, Y.-H., Dai, C., Huang, J., Hsieh, M., Lin, Z., Chen, S., Hsieh, M., Wang, L., Chuang, W., et al. (2010) · Hepatology International · doi:10.1007/s12072-010-9208-0 · Cited by 19 · see citing works
Kuang, M., Wang, S., Wu, M., Ning, G., Yao, Z., & Li, L. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.12.006 · Cited by 19 · see citing works
Drugs and Other Substances Interfering with Thyroid Function
Montanelli, L., Benvenga, S., Hegedüs, L., Vitti, P., Latrofa, F., & Duntas, L. H. (2018) · Endocrinology · doi:10.1007/978-3-319-45013-1_27 · Cited by 18 · see citing works
Adverse effects of high-dose interferon-α-2a treatment for chronic hepatitis B
Kartal, E. D., ALPAT, S. N., Özgüneş, İ., & Usluer, G. (2007) · Advances in Therapy · doi:10.1007/bf02877700 · Cited by 18 · see citing works
Andrade, L. J. D. O., D’Oliveira, A., Silva, C. A. C., Nunes, P., França, L. S., Malta, A. M. A., & Paraná, R. (2011) · PubMed · Cited by 17 · see citing works
Hwang, Y., Kim, W. K., Kwon, S. Y., Yu, H. M., Kim, J. H., & Choe, W. H. (2015) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2015.30.6.792 · Cited by 16 · see citing works
Endocrine and metabolic disorders in HTLV-1 infected patients
Alves, C., & Dourado, L. (2010) · The Brazilian Journal of Infectious Diseases · doi:10.1016/s1413-8670(10)70120-3 · Cited by 16 · see citing works
Munakata, K., Takashima, K., Nishiyama, M., Asano, N., Mase, A., Hioki, K., Ohnishi, Y., Yamamoto, M., & Watanabe, K. (2012) · BMC Genomics · doi:10.1186/1471-2164-13-30 · Cited by 16 · see citing works
Amino acid sequence homologies between HCV polyprotein and thyroid antigens
Martocchia, A., & Falaschi, P. (2007) · Internal and Emergency Medicine · doi:10.1007/s11739-007-0018-x · Cited by 16 · see citing works
Watanabe, T., Hirono, H., Hasegawa, K., Soga, K., & Shibasaki, K. (2011) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2011.06890.x · Cited by 16 · see citing works
Bakács, T. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.08.005 · Cited by 15 · see citing works
Tran, H. A., Levett-Jones, T. L., Ianna, E. A., Foy, A., & Reeves, G. E. M. (2012) · Endocrine Practice · doi:10.4158/ep12195.ra · Cited by 15 · see citing works
- Authors
- Prummel, M. F., & Laurberg, P.
- Affiliations
- Amsterdam UMC Location University of Amsterdam (NL)
- Aalborg University Hospital (DK)
- Venue
- Thyroid
- Publisher
- SAGE Publications
- Published
- 2003-06
- Volume
- 13
- Issue
- 6
- Pages
- 547-551
- ISSN
- 1050-7256 (ISSN-L)
- 1557-9077
- OpenAlex
- W1805116264
- Cited by
- 221
- References
- 28
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 1 · 2023: 4 · 2022: 6 · 2021: 3 · 2020: 5 · 2019: 5 · 2018: 8 · 2017: 6 · 2016: 10 · 2015: 6 · 2014: 8 · 2013: 5 · 2012: 18
- FWCI
- 8.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Thyroid (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Hepatology › Hepatitis C virus research
- Keywords
- interferon-alpha, autoimmune thyroid disease, hepatitis C virus, drug-induced autoimmunity, thyroid peroxidase antibodies, primary hypothyroidism, Graves' disease, destructive thyroiditis, sex differences, genetic susceptibility
- MeSH terms
- Autoantibodies, Autoimmune Diseases, Hepatitis C, Humans, Risk Factors, Sex Factors, Thyroid Diseases, Viruses, Incidence, Interferon-alpha
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
